HeartFlow, Inc., the developer of the HeartFlow Analysis deep learning technology that helps doctors interpret coronary computed tomography angiogram (CTA) scans, will go public through a reverse merger with a special purpose acquisition company (SPAC).
HeartFlow announced on 15 July plans to merge with Longview Acquisition Corp. II, a SPAC sponsored by Glenview Capital Management LLC and led by health care investor Larry Robbins